Efficacy and safety of Kami-guibi-tang for mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled trial
Abstract Background Mild cognitive impairment (MCI) is considered an intermediate phase between normal aging and dementia. As the majority of cases of amnestic MCI (aMCI) progress to Alzheimer's disease (AD), it is considered the prodromal stage of AD, and a treatment target for prevention of f...
Saved in:
Main Authors: | Hee-Yeon Shin (Author), Ha-Ri Kim (Author), Geon-Ho Jahng (Author), Chul Jin (Author), Seungwon Kwon (Author), Seung-Yeon Cho (Author), Seong-Uk Park (Author), Woo-Sang Jung (Author), Sang-Kwan Moon (Author), Chang-Nam Ko (Author), Jung-Mi Park (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Kami Guibi-tang in patients with mild cognitive impairment: study protocol for a phase III, randomized, double-blind, and placebo-controlled trial
by: Hee-Yeon Shin, et al.
Published: (2022) -
Effect of Kami Guibi-tang (KGT) in elderly subjects with insomnia: a study protocol from a single center, randomized, double-blind, placebo-controlled trial
by: Kyeong-Hwa Lee, et al.
Published: (2023) -
A Systematic Review of In Vivo Studies of the Efficacy of Herbal Medicines for Anti-Aging in the Last Five Years
by: Seung-Yeon Cho, et al.
Published: (2023) -
Traditional East Asian Herbal Medicine Treatment for Alzheimer's Disease: A Systematic Review and Meta-Analysis
by: JiEun Lee, et al.
Published: (2022) -
A Comparative Study on the Neuroprotective Effect of Geopung-Chunghyuldan on In Vitro Oxygen-Glucose Deprivation and In Vivo Permanent Middle Cerebral Artery Occlusion Models
by: Tae-Hoon Park, et al.
Published: (2023)